AbCellera Biologics Statistics
Total Valuation
ABCL has a market cap or net worth of $613.85 million. The enterprise value is $71.80 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ABCL has 297.99 million shares outstanding. The number of shares has increased by 1.78% in one year.
| Current Share Class | 297.99M |
| Shares Outstanding | 297.99M |
| Shares Change (YoY) | +1.78% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | 22.71% |
| Owned by Institutions (%) | 31.27% |
| Float | 202.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 26.34 |
| Forward PS | 18.28 |
| PB Ratio | 0.60 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.15, with a Debt / Equity ratio of 0.06.
| Current Ratio | 10.15 |
| Quick Ratio | 8.56 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -15.59% and return on invested capital (ROIC) is -15.86%.
| Return on Equity (ROE) | -15.59% |
| Return on Assets (ROA) | -12.94% |
| Return on Invested Capital (ROIC) | -15.86% |
| Return on Capital Employed (ROCE) | -22.90% |
| Revenue Per Employee | $38,782 |
| Profits Per Employee | -$281,658 |
| Employee Count | 596 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -42.76M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.21% in the last 52 weeks. The beta is 0.46, so ABCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -46.21% |
| 50-Day Moving Average | 2.33 |
| 200-Day Moving Average | 2.72 |
| Relative Strength Index (RSI) | 36.82 |
| Average Volume (20 Days) | 4,015,786 |
Short Selling Information
The latest short interest is 23.01 million, so 7.72% of the outstanding shares have been sold short.
| Short Interest | 23.01M |
| Short Previous Month | 23.78M |
| Short % of Shares Out | 7.72% |
| Short % of Float | 11.35% |
| Short Ratio (days to cover) | 5.88 |
Income Statement
In the last 12 months, ABCL had revenue of $23.11 million and -$167.87 million in losses. Loss per share was -$0.57.
| Revenue | 23.11M |
| Gross Profit | -144.15M |
| Operating Income | -290.53M |
| Pretax Income | -178.81M |
| Net Income | -167.87M |
| EBITDA | -231.20M |
| EBIT | -290.53M |
| Loss Per Share | -$0.57 |
Full Income StatementBalance Sheet
The company has $605.27 million in cash and $63.21 million in debt, giving a net cash position of $542.06 million or $1.82 per share.
| Cash & Cash Equivalents | 605.27M |
| Total Debt | 63.21M |
| Net Cash | 542.06M |
| Net Cash Per Share | $1.82 |
| Equity (Book Value) | 1.02B |
| Book Value Per Share | 3.44 |
| Working Capital | 689.58M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$78.40 million and capital expenditures -$64.89 million, giving a free cash flow of -$143.29 million.
| Operating Cash Flow | -78.40M |
| Capital Expenditures | -64.89M |
| Free Cash Flow | -143.29M |
| FCF Per Share | -$0.48 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,256.95% |
| Pretax Margin | -911.27% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |